Marrero, Louisiana 70072


Purpose:

That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.


Study summary:

The study is a retrospective review of the PI's experience using SPECT brain imaging and hyperbaric oxygen therapy in the diagnosis and treatment of non-acute phases of carbon monoxide poisoning. The purpose is to see if the SPECT brain imaging is consistent with the clinical condition and cognitive testing on the patients.


Criteria:

Inclusion Criteria: - Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment Exclusion Criteria:


Study is Available At:


Original ID:

LSU IRB #6626


NCT ID:

NCT00596180


Secondary ID:


Study Acronym:


Brief Title:

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning


Official Title:

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning


Overall Status:

Recruiting


Study Phase:

N/A


Genders:

N/A


Minimum Age:

N/A


Maximum Age:

N/A


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Louisiana State University Health Sciences Center in New Orleans


Oversight Authority:

United States: Institutional Review Board


Reasons Why Stopped:


Study Type:

Observational


Study Design:


Number of Arms:

0


Number of Groups:

1


Total Enrollment:

40


Enrollment Type:

Anticipated


Overall Contact Information

Official Name:Paul G Harch, M.D.
Principal Investigator
LSU School of Medicine
Primary Contact:Paul G Harch, M.D.
504-309-4948
paulharchmd@gmail.com

Study Dates

Start Date:January 2007
Completion Date:December 2019
Completion Type:Anticipated
Primary Completion Date:December 2018
Primary Completion Type:Anticipated
Verification Date:April 2017
Last Changed Date:April 16, 2017
First Received Date:January 4, 2008

Study Outcomes

Outcome Type:Secondary Outcome
Measure:Neuropsychological testing
Time Frame:After the final HBOT
Safety Issues:False
Description:Neuropsychological testing performed after the final HBOT in those who had neuropsychological testing before HBOT
Outcome Type:Secondary Outcome
Measure:clinical history and physical exam
Time Frame:after completion of HBOT
Safety Issues:False
Outcome Type:Primary Outcome
Measure:SPECT brain imaging
Time Frame:after completion of HBOT
Safety Issues:False

Study Interventions

Intervention Type:Drug
Name:HBOT
Description:total body exposure to greater than atmospheric pressure oxygen
Arm Name:1

Study Arms

Study Arm Type:Other
Arm Name:1
Description:HBOT

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:Paul G. Harch, M.D.
Agency Class:Other
Agency Type:Collaborator
Agency Name:Harch Hyperbaric Research Foundation

Samples and Retentions

Study Population: Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment. Retrospective chart review
Sample Method:Non-Probability Sample

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


If you would like to be contacted by the clinical trial representative please fill out the form below.